(NASDAQ: SHC) Sotera Health Co's forecast annual revenue growth rate of 5.73% is not forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 8.05%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.73%.
Sotera Health Co's revenue in 2026 is $1,189,139,000.On average, 12 Wall Street analysts forecast SHC's revenue for 2026 to be $357,884,577,470, with the lowest SHC revenue forecast at $345,337,229,734, and the highest SHC revenue forecast at $374,139,096,128. On average, 12 Wall Street analysts forecast SHC's revenue for 2027 to be $378,701,768,032, with the lowest SHC revenue forecast at $365,298,919,314, and the highest SHC revenue forecast at $396,096,954,666.
In 2028, SHC is forecast to generate $401,229,960,558 in revenue, with the lowest revenue forecast at $386,116,109,876 and the highest revenue forecast at $420,336,149,156.